Novel, high incidence exercise-induced muscle bleeding model in hemophilia B mice: rationale, development and prophylactic intervention

J Thromb Haemost. 2015 Jan;13(1):82-91. doi: 10.1111/jth.12775. Epub 2014 Dec 11.

Abstract

Introduction: Muscle hematomas are the second most common complication of hemophilia and insufficient treatment may result in serious and even life-threatening complications. Hemophilic dogs and rats do experience spontaneous muscle bleeding, but currently, no experimental animal model is available specifically investigating spontaneous muscle bleeds in a hemophilic setting.

Aim: The objective of this study was to develop a model of spontaneous muscle bleeds in hemophilia B mice. We hypothesized that treadmill exercise would induce muscle bleeds in hemophilia B mice but not in normal non-hemophilic mice and that treatment with recombinant factor IX (rFIX) before treadmill exercise could prevent the occurrence of pathology.

Methods: A total of 203 mice (123 F9-KO and 80 C57BL/6NTac) were included in three separate studies: (i) the model implementation study investigating the bleeding pattern in hemophilia B mice after treadmill exercise; (ii) a study evaluating the pharmacokinetics of recombinant FIX (rFIX) in hemophilia B mice and based on these data; (iii) the treatment study, which tested therapeutic intervention with rFIX. At termination of the treadmill studies the presence of bleeds was evaluated.

Results: Treadmill exercise resulted in a high incidence of muscle bleeds in F9-KO mice but not in C57BL/6NTac mice. Treating hemophilia B mice with rFIX before treadmill exercise prevented muscle bleeds.

Conclusion: A novel model of muscle bleeds in hemophilia B mice, responsive to rFIX, has been developed.

Keywords: animal model; hematoma; hemophilia B; muscles; treadmill test.

MeSH terms

  • Animals
  • Biomarkers / blood
  • Coagulants / pharmacokinetics
  • Coagulants / pharmacology*
  • Disease Models, Animal
  • Electric Stimulation
  • Factor IX / genetics
  • Factor IX / metabolism
  • Factor IX / pharmacokinetics
  • Factor IX / pharmacology*
  • Female
  • Hematoma / blood
  • Hematoma / genetics
  • Hematoma / prevention & control*
  • Hemophilia B / blood
  • Hemophilia B / genetics
  • Hemophilia B / prevention & control*
  • Hemorrhage / blood
  • Hemorrhage / genetics
  • Hemorrhage / prevention & control*
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscular Diseases / blood
  • Muscular Diseases / genetics
  • Muscular Diseases / prevention & control*
  • Physical Exertion*
  • Recombinant Proteins / pharmacology

Substances

  • Biomarkers
  • Coagulants
  • Recombinant Proteins
  • Factor IX